





SpaceX shares are down ~13% since their market debut, and the article argues the stock’s current valuation (~100x sales) leaves limited margin of safety. Even with a hypothetical 20% annual revenue growth to ~$116B by 2036 and a 6x sales valuation (implied ~$700B market cap vs ~$1.8T today), a $5,000 investment could fall below $2,000. The piece suggests waiting for a more favorable price, with upside only if revenue growth far exceeds baseline scenarios.
This is less a fundamentals update than a reminder that duration is the real enemy in very high-multiple private assets. At roughly 100x sales, even strong top-line compounding can be overwhelmed by multiple normalization; the equity is behaving like a long-dated call option whose terminal value is dominated by the clearing multiple, not the growth rate. That matters because the private mark becomes a reference price for every late-stage investor and employee liquidity event in adjacent space/software assets.
Over the next 1-3 months, the most plausible spillover is sentiment pressure on public, narrative-driven aerospace names such as RKLB, ASTS, and LUNR, which trade on TAM credibility and future financing access more than near-term earnings. If the market starts discounting SpaceX as an unattainable comp set, crossover capital may demand harsher terms from unprofitable peers, compressing secondary valuations and slowing follow-on raises. The beneficiaries are slower-growth cash generative primes like LMT, NOC, and RTX, but only as a relative rotation into defensible margins.
Contrarian view: the consensus is still anchoring on revenue growth and underweighting capex intensity plus terminal multiple compression. The key falsifier is a new private tender or financing that holds or raises the mark, or evidence that Starlink/launch economics are translating into free-cash-flow inflection fast enough to defend a premium multiple. Absent that, the current setup is more likely to hurt late-stage holders than create tradable upside in the stock itself.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment